Valuation: 3-D Matrix, Ltd.

Market Cap 40.83B 255M 231M 214M 193M 364M 24.08B 377M 2.57B 1.02B 12.86B 958M 938M P/E 2025
-5x
P/E 2026 16.6x
Enterprise Value 38.6B 241M 219M 202M 183M 344M 22.76B 356M 2.43B 964M 12.16B 906M 887M EV / Sales 2025
2.2x
EV / Sales 2026 5.86x
Free-Float
94.14%
Yield 2025 *
-
Yield 2026 -
1 day+0.63%
1 week-0.93%
Current month-10.14%
1 month-21.62%
3 months-11.14%
6 months-33.95%
Current year-11.14%
1 week 284
Extreme 284
329
1 month 284
Extreme 284
401
Current year 284
Extreme 284
793
1 year 284
Extreme 284
793
3 years 97
Extreme 97
793
5 years 97
Extreme 97
793
10 years 97
Extreme 97
1,144
Manager TitleAgeSince
President 52 01/03/2016
Investor Relations Contact 59 -
Corporate Officer/Principal 51 01/07/2019
Director TitleAgeSince
Chairman 72 19/05/2004
Director/Board Member 52 01/07/2007
Director/Board Member 46 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-0.93%-5.90%+109.87% 254M
-2.69%-5.28%+58.42%+65.89% 68.45B
-0.92%+7.70%+12.90%+93.35% 61.31B
0.00%-0.95%+20.09%+99.04% 55.73B
+0.05%+2.22%+12.94%+109.21% 47.51B
-2.24%-2.05%+19.11%+37.48% 44.68B
-2.32%-10.26%+168.03%+778.17% 38.14B
+2.15%-0.47%+22.85%+56.09% 35.85B
-2.32%-5.14%+75.43%+60.15% 33.05B
+2.61%+5.78%-36.63%+406.34% 25.9B
Average -0.46%+2.02%+34.72%+181.56% 41B
Weighted average by Cap. -0.82%+2.25%+39.30%+162.70%

Financials

2025 2026
Net sales 6.93B 43.37M 39.3M 36.35M 32.8M 61.81M 4.09B 63.99M 437M 173M 2.18B 163M 159M 10.89B 68.09M 61.7M 57.07M 51.49M 97.04M 6.42B 100M 686M 272M 3.43B 256M 250M
Net income -2.5B -15.64M -14.18M -13.11M -11.83M -22.29M -1.47B -23.08M -158M -62.45M -788M -58.7M -57.46M 4.16B 25.99M 23.55M 21.78M 19.65M 37.04M 2.45B 38.34M 262M 104M 1.31B 97.53M 95.46M
Net Debt 1.36B 8.51M 7.71M 7.13M 6.43M 12.12M 802M 12.55M 85.65M 33.96M 428M 31.92M 31.24M -2.23B -13.95M -12.64M -11.69M -10.55M -19.88M -1.32B -20.58M -140M -55.69M -703M -52.34M -51.23M
Projected Income Statement - Annual - 3-D Matrix, Ltd.
Logo 3-D Matrix, Ltd.
3-D Matrix Ltd is a Japan-based company mainly engaged in medical products business. Its Medical Products Business consists of the development and sales of medical products. Based on self-assembling peptide technology, it conducts research and development of medical devices and pharmaceuticals in the surgical, tissue regeneration, and drug delivery system (DDS) fields. Major development pipelines include absorbable topical hemostatic agents, mucosal elevation agents, post-bleeding prevention agents, next-generation hemostatic agents, and adhesion prevention agents in the surgical field, wound healing agents and alveolar bone reconstruction agents in the tissue regeneration field, and DDS for nucleic acid drugs in the DDS field.
Employees
129
Date Price Change Volume
13/11/26 ¥319.00 +0.63% 1,228,900
12/11/26 ¥317.00 -2.76% 1,065,000
11/11/26 ¥326.00 +2.52% 1,394,700
10/11/26 ¥318.00 +7.80% 2,244,600
09/11/26 ¥295.00 -0.34% 3,725,100
  1. Stock Market
  2. Stocks
  3. 7777 Stock